G40.842
KCNQ2-related epilepsy, not intractable, without status epilepticus
Clinical Classification Guidelines
Inclusion Terms
- KCNQ2-related epilepsy NOS
Medical Intelligence & Overview
KCNQ2-related epilepsy is a neurological condition characterized by recurring seizures originating from abnormal electrical activity in the brain. This particular form, classified under ICD-10 code G40.842, refers to a type of epilepsy linked to mutations in the KCNQ2 gene. It is described as non-intractable, meaning it can often be managed with treatment, and it typically does not involve episodes of prolonged seizure activity known as status epilepticus. Patients with this diagnosis are considered to have KCNQ2-related epilepsy not otherwise specified (NOS), reflecting some variability in presentation and severity.
Causes & Symptoms
Clinical Causes: Mutations or genetic variations in the KCNQ2 gene, which encodes a potassium channel important for regulating nerve activity. Hereditary factors passed from parent to child, with some cases arising spontaneously. Possible environmental factors, though genetic mutations are primary causes.
Key Symptoms: Frequent seizures of various types, often starting in early infancy or childhood. Mild to moderate developmental delays or intellectual challenges in some cases. Possible focal seizures affecting specific parts of the body or generalized seizures involving the entire brain. Absence of status epilepticus, which is prolonged or life-threatening seizures.
Diagnostic & Treatment
Diagnosis Path: Diagnostic processes typically involve a detailed medical history and seizure description, neurological examinations, and confirmation through electroencephalogram (EEG) testing. Genetic testing for mutations in the KCNQ2 gene supports the diagnosis. Additional imaging tests, such as MRI, may be used to rule out other conditions. The classification as 'not intractable' and 'without status epilepticus' is based on seizure frequency, response to treatment, and absence of severe seizure episodes.
Treatment Protocols: Management generally includes antiepileptic medications to control seizure activity. Common options may involve drugs like sodium channel blockers or other medications effective against KCNQ2-related seizures. Regular follow-up with a healthcare provider helps monitor seizure control and developmental progress. In some cases, supportive therapies, such as physical, occupational, or speech therapy, are recommended. The goal is to reduce seizure frequency, improve quality of life, and support developmental needs.
Clinical Advice & FAQs
Billing Guidance
Is G40.842 a billable ICD-10 code?
Yes, G40.842 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G40.842?
Clinical documentation must specify the nature of KCNQ2-related epilepsy, not intractable, without status epilepticus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference